![Robert Hershberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Hershberg
President chez
HILLEVAX, INC.
Fortune : 972 536 $ au 31/05/2026
Profil
Robert M.
Hershberg was the founder of VentiRx Pharmaceuticals, Inc., founded in 2006, where the titles held included President, Chief Executive Officer & Director from 2012 to 2017.
Dr. Hershberg is the founder of HilleVax, Inc., founded in 2020, holding the title of President.
Dr. Hershberg is the founder of Cajal Therapeutics, founded in 2020, serving as Executive Chairman since 2020.
Current jobs include Vice Chairman at Recursion Pharmaceuticals, Inc. since 2019, Independent Director at Adaptive Biotechnologies Corp.
since 2013, Senior Advisor at Frazier Management LLC since 2020, Member at UW Medicine, Director at Beckley Psytech Ltd. since 2024, Independent Director at Atai Beckley, Inc. since 2025.
Former jobs include Independent Director at NS Wind Down Co., Inc. from 2015 to 2022, Independent Director at Silverback Therapeutics, Inc. from 2017 to 2022, Independent Director at Fate Therapeutics, Inc. from 2020 to 2024, Director at Guide Therapeutics, Inc., Non-Executive Director at Atai Beckley NV, Vice President-Medical Genetics at Corixa Corp.
from 2001 to 2003, Chief Medical Officer & Senior Vice President at Dendreon Corp.
from 2003 to 2006, Assistant Professor at Harvard Medical School, Chief Scientific Officer & Executive VP at Celgene Corp.
from 2017 to 2020.
Education includes a doctorate from The Salk Institute for Biological Studies and both undergraduate and doctorate degrees from the University of California, Los Angeles.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2026 | 46 722 ( 0,03 % ) | 707 838 $ | 31/05/2026 | |
| 21/04/2026 | 73 732 ( 0,01 % ) | 264 698 $ | 31/05/2026 | |
-.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Robert Hershberg
| Sociétés | Poste | Début |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Directeur/Membre du Conseil | 01/02/2013 |
| RECURSION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2026 |
| HILLEVAX, INC. | President | 25/03/2020 |
Beckley Psytech Ltd.
 Beckley Psytech Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicine for mental health treatment | Directeur/Membre du Conseil | 01/06/2024 |
Cajal Neuroscience, Inc.
 Cajal Neuroscience, Inc. BiotechnologyHealth Technology Develops novel medicines for patients with neurodegenerative disorders | Fondateur | 01/01/2020 |
UW Medicine
 UW Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 01/03/2020 |
Anciens postes connus de Robert Hershberg
| Sociétés | Poste | Fin |
|---|---|---|
| FATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 07/06/2024 |
| ARS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/11/2022 |
| ░░ ░░░░ ░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Hershberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
The Salk Institute for Biological Studies
 The Salk Institute for Biological Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Develops and manufactures oncology and immunology products | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines | Health Technology |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NS Wind Down Co., Inc.
 NS Wind Down Co., Inc. Medical SpecialtiesHealth Technology Develops and manufactures life science tools for translational research and molecular diagnostic products | Health Technology |
Fate Therapeutics, Inc.
 Fate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UW Medicine
UW Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Guide Therapeutics, Inc.
 Guide Therapeutics, Inc. BiotechnologyHealth Technology Develops biophotonic technology platform for the early detection of disease that leads to cancer | Health Technology |
Beckley Psytech Ltd.
Beckley Psytech Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicine for mental health treatment | Health Technology |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Develops novel medicines for patients with neurodegenerative disorders | Health Technology |
ATAI Life Sciences NV
 ATAI Life Sciences NV Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
HilleVax, Inc.
 HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
